trending Market Intelligence /marketintelligence/en/news-insights/trending/uawvjG8T2h4WToRo5KCFRw2 content esgSubNav
In This List

Seacoast Capital invests $30M in SkinCure Oncology

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Podcast

Street Talk Episode 87

Blog

A New Dawn for European Bank M&A Top 5 Trends

Blog

Insight Weekly: US banks' loan growth; record share buybacks; utility M&A outlook


Seacoast Capital invests $30M in SkinCure Oncology

Lower-middle-market private equity group Seacoast Capital Managers LLC invested $30 million worth of syndicated growth equity for a noncontrolling stake in Illinois-based Skincure Oncology LLC.

The investment was used to aid a shareholder dividend and capitalize SkinCure for future growth.

Founded in 2016, SkinCure provides management services and solutions to dermatologists and a noninvasive alternative for treating nonmelanoma skin cancer.